Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...
Bristol Myers Squibb’s $4.1 Billion Acquisition of RayzeBio
RayzeBio’s $160 Million Series D Financing
Wilson Sonsini advised RayzeBio on the deal. RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, announced a $160 million...